Rite Aid (RAD) Comps Up 2.9% in December
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Rite-Aid (RAD) December Results Positive Despite Flu-Relates Weakness in Scripts - Analyst Comments
January 3, 2014 10:20 AM ESTDeutsche Bank maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $7.00. For the four weeks ended Dec. 28, 2013, Rite-Aid same store sales increased 2.9 percent over the prior-year period. December front-end same store sales increased 1.0 percent. Pharmacy same store sales, which included an approximate 102 basis points negative impact from new generic... More
